Glucose-induced insulin secretion and pattern of exocrine pancreatic enzymes in the rat following oral and parenteral trypsin inhibitor administration.
D000284:Administration, Oral; D000681:Amylases / Q000378:metabolism*; D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D003864:Depression, Chemical; D005947:Glucose / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008049:Lipase / Q000378:metabolism*; D008297:Male; D009929:Organ Size; D010179:Pancreas / Q000033:anatomy & histology / Q000187:drug effects* / Q000201:enzymology; D011863:Radioimmunoassay; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical; D013997:Time Factors; D014362:Trypsinogen / Q000378:metabolism*
D001786:Blood Glucose; D007328:Insulin; D014362:Trypsinogen; D007611:Aprotinin; D008049:Lipase; D000681:Amylases; D005947:Glucose